Real Estate · Real Estate

IIPR INNOVATIVE INDUSTRIAL PROPERTIES INC SEC Filings & Insider Trading Activity 2026

company
CIK 167757697 filings
Russell 2000

IIPR at a glance

INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR, SEC CIK 1677576) filed its latest 10-K annual report on February 24, 2026, a 10-Q quarterly report on November 3, 2026, an 8-K current report on November 9, 2026 and Form 4 insider filings as recently as October 13, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) reported revenue of $266.0 million (down 13.8% from FY2024) and net income of $118.2 million. Diluted EPS was $3.93.
  • As of September 30, 2026, 29 institutional investment managers tracked by SignalX reported holding INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) shares worth $708.9 million in 13F-HR filings.
  • The most recent insider open-market purchase reported on Form 4 was by Gold Alan D on October 8, 2026 of 40,000 shares at $25.00 per share.
  • In the last 90 days, IIPR insiders reported 2 open-market purchases ($1.0M) and 1 open-market sale ($34K) on Form 4, a net purchase of $996K.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$266.0M
−13.8% vs prior year
Insiders · 90 days
2 buys · 1 sell
Net +$996K
13F holders
29 funds
$708.9M · −1 vs prior quarter
Latest 8-K
Nov 9, 2026
Item 8.01

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Dec 31, 2025

Full analysis →

Business Overview

  • Core business model: Internally-managed REIT acquiring, owning, managing specialized industrial properties leased primarily to state-licensed cannabis operators
  • New life science segment: $50M investment in IQHQ REIT preferred stock plus $100M loan under IQHQ Credit Facility, expanding into life sciences real estate financing
  • Strategic shift: Growth strategy broadened from cannabis-focused real estate to include life science investments and diversified real estate-related assets
  • Portfolio scale: Owned 111 properties totaling 8.9 million rentable sq ft across 19 states, 96.7% leased with 12.8 years weighted-average lease term
  • Noteworthy fact: Launched $100M share repurchase program in 2025 and increased Revolving Credit Facility to $87.5M with $27.5M drawn as of year-end

Risk Factors

  • Regulatory risk: Continued federal illegality of cannabis restricts operators' access to traditional bank financing and public capital markets
  • Macroeconomic threat: Tenant defaults from PharmaCann, Gold Flora, TILT, and 4Front caused $46.9M rental revenue decline in 2025
  • Operational vulnerability: Inflation, tariffs, and supply chain issues increase capital and operating costs, potentially delaying tenant expansions
  • Competitive risk: Intense competition from investors and cannabis operators may limit property acquisition opportunities and pressure rental rates
  • Financial risk: $291.2M Notes due May 2026 maturity raises substantial doubt about going concern; refinancing not yet secured

Management Discussion & Analysis

  • Revenue not explicitly stated; rental revenue driven by 109 operating cannabis-related properties, 96.7% leased as of Dec 31, 2025
  • Best performing segment implied: cannabis-related real estate with 109 operating properties, 96.7% leased; no detailed segment financials
  • Invested $2.5B in properties, committed $6.5M for tenant/vendor improvements; cash flow details, buybacks, dividends, or capex not provided
  • Forward outlook highlights regulatory, economic, and market risks in cannabis; tenant defaults risk due to license renewals, industry headwinds, uncertain lease renewals

AI summary of the IIPR 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • Newly added IQHQ investment risk: $411.0 million exposure represented 16% of total assets as of September 30, 2026
  • Most material update: approximately $134.0 million IQHQ Alewife commitment remained unfunded, with advance timing outside IIP’s control
  • Regulatory risk: IRS challenge to Alewife loan’s REIT treatment could jeopardize REIT qualification
  • Operational risk: IQHQ borrower deterioration could impair repayment across multiple investments simultaneously
  • Financial risk: IQHQ investments secure the IIP Life Science Credit Facility, potentially restricting liquidity and borrowing capacity

Management Discussion & Analysis

  • Revenue $64.9M, up 0.4% YoY from $64.7M, driven by rent escalations, re-leasing and security-deposit applications
  • Net income $31.9M vs $29.3M YoY, net margin 49.1% vs 45.3%
  • Best segment: Life Science, $10.4M quarterly net income vs insignificant prior-year income
  • Operating cash flow $150.4M for nine months, up from $148.3M; ending cash and restricted cash $145.3M
  • Cannabis headwinds: tenant defaults, pricing pressure, constrained capital and uncertainty around DEA rescheduling implementation

AI summary of the IIPR 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 9, 2026Full analysis →

Item 8.01: Other Events

  • ATM program expanded to include 9.25% Series B preferred stock alongside common and 9.00% Series A preferred stock
  • Up to $500 million aggregate offering capacity under the equity distribution agreements
Filed Nov 6, 2026Full analysis →

Item 5.03: Amendments to Articles of Incorporation or Bylaws

  • Item 5.03 incorporates Item 3.03 details on Articles Supplementary into the company’s governing documents

Item 3.03: Material Modification to Rights of Security Holders

  • Authorized Series B Preferred Stock expanded by 16,100,000 shares to 18,400,000 total
  • Series B carries a 9.25% cumulative dividend, increasing potential preferred financing capacity
Filed Nov 2, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q3 2026 results covered the quarter ended September 30, 2026
  • Press release and supplemental financial information issued November 2, 2026

Item 7.01: Regulation FD Disclosure

  • Investor presentation released November 2, 2026 under Regulation FD
  • Presentation contains the substantive investor update, available as Exhibit 99.3 and on IIPR’s website

Item EX-99.1: Item EX-99.1

  • Q3 revenue $64.9M, net income $28.7M, diluted EPS $0.99
  • AFFO $1.96 per share, up from $1.71, supporting the $1.90 quarterly dividend

Item EX-99.3: Item EX-99.3

  • Q3 2026 revenue reached $64.9M, supporting continued cash-flow generation from IIPR’s $2.4B triple-net lease portfolio
  • Life sciences exposure expanded through IQHQ, including a $245M Alewife Park mezzanine commitment yielding an expected 15.8%

Item EX-99.2: Item EX-99.2

  • Q3 2026 supplemental package shows revenue $64.9M and diluted AFFO $1.96 per share, supporting the $1.90 dividend
  • AFFO payout ratio improved to 97% from 111% in Q3 2025, reducing near-term dividend coverage pressure

AI summaries of IIPR 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for IIPR

Don't miss the next IIPR filing

  • Alerts as it files. A push when IIPR files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut IIPR, by share count.
  • Ask anything. An AI agent that reads every IIPR filing and answers with sources.

IIPR alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Gold Alan DBuyOct 8, 2026$25.00
Shoemaker ScottSellSep 15, 2026$56.36
Ives Bruce AlanBuyAug 31, 2026$56.70
Smithers Paul E.AJun 19, 2026-
Smith David JonAJun 19, 2026-
Gold Alan DAJun 19, 2026-
Ives Bruce AlanAJun 9, 2026-
Shoemaker ScottAJun 9, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue$309.5M$308.5M$266.0M
Operating Income$174.6M$168.3M$124.1M
Net Income$165.6M$161.7M$118.2M
Op. Margin56.4%54.6%46.7%
Net Margin53.5%52.4%44.5%
Balance Sheet
Total Assets$2.4B$2.4B$2.4B
Equity$2.0B$1.9B$1.8B
ROE8.5%8.3%6.4%
Per Share
EPS-$5.52$3.93
Cash Flow
Operating CF$255.5M$258.4M$198.2M

Source: XBRL data in INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate IIPR share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
IIPR shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202629$708.9M
Q2 202630$867.7M
Q1 202628$688.6M
Q4 202525$681.2M
Q3 202526$763.9M
Q2 202529$788.8M
Q1 202527$508.1M
Q4 202423$549.4M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
New Positions
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 217 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

IIPR filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
8-KNov 9, 2026Analysis-
8-KNov 6, 2026Analysis-
10-QNov 3, 2026Analysis
8-KNov 2, 2026Analysis-
8-KOct 27, 2026Analysis-
8-KOct 14, 2026Analysis-
4Oct 13, 2026--
8-KOct 1, 2026Analysis-
8-KSep 25, 2026Analysis-
4Sep 17, 2026--
8-KSep 1, 2026Analysis-
4Sep 1, 2026--
10-QAug 4, 2026Analysis
8-KAug 3, 2026Analysis-
8-KJul 21, 2026Analysis-
4Jun 23, 2026--
4Jun 23, 2026--
4Jun 23, 2026--
8-KJun 15, 2026Analysis-
8-KJun 11, 2026Analysis-
4Jun 11, 2026--
4Jun 10, 2026-
4Jun 10, 2026-
8-KJun 9, 2026-
8-KMay 22, 2026-

Related Real Estate companies

All Real Estate →

IIPR SEC filings: frequently asked questions

Are IIPR insiders buying or selling?

In the last 90 days, INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) officers, directors and 10% owners reported 2 open-market purchases worth $1.0 million by 2 insiders and 1 open-market sale worth $34,436 by 1 insider on Form 4, a net purchase of $995,502. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold IIPR stock?

As of September 30, 2026, the largest INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) holders among the 13F filers tracked by SignalX were BlackRock ($259.2 million), Vanguard Portfolio Management LLC ($147.3 million), State Street Corp ($87.7 million), Vanguard Capital Management LLC ($65.4 million), Invesco Ltd ($29.2 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was IIPR's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) reported revenue of $266.0 million (down 13.8% from FY2024) and net income of $118.2 million. Diluted EPS was $3.93. The figures come from the XBRL data in the 10-K.

What are the main risks in IIPR's latest 10-K?

In the 10-K filed February 24, 2026, INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) flagged: Regulatory risk: Continued federal illegality of cannabis restricts operators' access to traditional bank financing and public capital markets. Macroeconomic threat: Tenant defaults from PharmaCann, Gold Flora, TILT, and 4Front caused $46.9M rental revenue decline in 2025. (AI summary of the Risk Factors section.)

What did IIPR report in its latest 8-K?

INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) filed an 8-K on November 9, 2026 reporting Item 8.01 (Other Events). ATM program expanded to include 9.25% Series B preferred stock alongside common and 9.00% Series A preferred stock.

What are the latest IIPR SEC filings?

INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) filed its latest 10-K annual report on February 24, 2026, a 10-Q quarterly report on November 3, 2026, an 8-K current report on November 9, 2026 and a Form 4 insider filing on October 13, 2026.

What is IIPR's SEC CIK number?

INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR)'s SEC Central Index Key (CIK) is 1677576. EDGAR lists every IIPR filing under that number.

Ask anything about IIPR

The research agent reads IIPR's filings, financials, insider trades and 13F holders, then answers with sources.